Hikma delivers another strong financial and operational performance, and improves FY outlook for Generics

London, United Kingdom, (AETOSWire) – Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its interim results for the six months ended 30 June 2021. Siggi Olafsson, Chief Executive Officer of Hikma, said: “Once again, we have benefited from the resilience of our portfolio and our flexibleContinue Reading